Aurobindo Pharma share price jumps 17% after receiving VAI status for Hyderabad facility
Updated : April 21, 2020 11:52 AM IST
Aurobindo Pharma's shares climbed over 17 percent to Rs 633 on the NSE.
US FDA classified the company's Unit IV of Hyderabad plant as VAI (voluntary action indicated).
. Since March 24, the stock has soared 100 percent to current levels.